{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:40:50Z","timestamp":1767008450816},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[1995]]},"DOI":"10.1007\/bf00917830","type":"journal-article","created":{"date-parts":[[2005,1,2]],"date-time":"2005-01-02T06:42:39Z","timestamp":1104648159000},"page":"277-280","source":"Crossref","is-referenced-by-count":11,"title":["The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery"],"prefix":"10.1007","volume":"18","author":[{"given":"Andreas","family":"Wedrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert","family":"Menapace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"M\ufffdhlbauer-Ries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.CIR.72.1.178","volume":"72","author":"B Agnelli","year":"1985","unstructured":"Agnelli B, Buchanan MR, Fernandez F et al. A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. Circulation 1985; 72: 178?82.","journal-title":"Circulation"},{"key":"CR2","first-page":"146","volume":"231","author":"D Collen","year":"1984","unstructured":"Collen D, Stassen JM, Marafino BJ et al. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells. J Pharmacol Exp Ther 1984; 231: 146?52.","journal-title":"J Pharmacol Exp Ther"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0002-9394(87)90175-9","volume":"104","author":"FH Lambrou","year":"1987","unstructured":"Lambrou FH, Snyder RW, Williams GA et al. Treatment of experimental intravitreal fibrin with tissue plasminogen activator. Am J Ophthalmol 1987; 104: 619?23.","journal-title":"Am J Ophthalmol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/archopht.1987.01060090135044","volume":"105","author":"RW Snyder","year":"1987","unstructured":"Snyder RW, Lambrou FH, Williams GA. Intraocular fibrinolysis with recombinant human tissue plasminogen activator. Arch Ophthalmol 1987; 105: 1277?80.","journal-title":"Arch Ophthalmol"},{"key":"CR5","first-page":"663","volume":"20","author":"S Fourman","year":"1989","unstructured":"Fourman S, Vaid K. Effects of tissue plasminogen activator on glaucoma filter blebs in rabbits. Ophthalmic Surg 1989; 20: 663?7.","journal-title":"Ophthalmic Surg"},{"issue":"Suppl","key":"CR6","first-page":"418","volume":"30","author":"RR Ozment","year":"1989","unstructured":"Ozment RR, Liaw ZC, Krug J et al. Use of tissue plasminogen activator in experimental filtration surgery. Invest Ophthalmol Vis Sci 1989; 30 (Suppl): 418.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/jop.1991.7.9","volume":"7","author":"GH Strauss","year":"1991","unstructured":"Strauss GH, Dunn ET, D\ufffdnn RC et al. Subconjunctival high dose plasminogen activator in rabbit filtration surgery. J Ocul Pharmacol 1991;7: 9?19.","journal-title":"J Ocul Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/archopht.1987.01060070139044","volume":"105","author":"FH Lambrou","year":"1987","unstructured":"Lambrou FH, Snyder RW, Williams GA. Use of tissue plasminogen activator in experimental hyphema. Arch Ophthalmol 1987; 105: 995?7.","journal-title":"Arch Ophthalmol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archopht.1991.01080020118055","volume":"109","author":"GR Howard","year":"1991","unstructured":"Howard GR, Vukich J, Fiscella RG et al. Intraocular tissue plasminogen activator in a rabbit model of traumatic hyphema. Arch Ophthalmol 1991; 109: 272?4.","journal-title":"Arch Ophthalmol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archopht.1991.01080050134044","volume":"109","author":"WD Irvine","year":"1991","unstructured":"Irvine WD, Johnson MW, Hernandez E, Olsen KR. Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes. Arch Ophthalmol 1991; 109: 718?22.","journal-title":"Arch Ophthalmol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archopht.1990.01070040111042","volume":"108","author":"MW Johnson","year":"1990","unstructured":"Johnson MW, Olsen KR, Hernandez E et al. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol 1990; 108: 259?63.","journal-title":"Arch Ophthalmol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0161-6420(90)32618-0","volume":"97","author":"GL Jaffe","year":"1990","unstructured":"Jaffe GL, Abrams GW, Williams GA, Han DP. Tissue plasminogen activator for postvitrectomy fibrin formation. Ophthalmology 1990; 97: 184?9.","journal-title":"Ophthalmology"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9394(14)74622-7","volume":"109","author":"RW Snyder","year":"1990","unstructured":"Snyder RW, Sherman MD, Allison RW. Intracameral tissue plasminogen activator for treatment of excessive fibrin response after penetrating keratoplasty. Am J Ophthalmol 1990; 109: 483?4.","journal-title":"Am J Ophthalmol"},{"key":"CR14","first-page":"354","volume":"1","author":"F K\ufffdrner","year":"1992","unstructured":"K\ufffdrner F, Boehnke M. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis. German J Ophthalmol 1992; 1: 354?60.","journal-title":"German J Ophthalmol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01046426","volume":"15","author":"N Baziuk","year":"1991","unstructured":"Baziuk N, Fang T, Peyman GA, Gremillion CM Jr. Intravitreal recombinant tissue plasminogen activator in the treatment of experimentally induced bacterial endophthalmitis. Intern Ophthalmol 1991; 15: 79?86.","journal-title":"Intern Ophthalmol"},{"key":"CR16","doi-asserted-by":"crossref","unstructured":"Wedrich A, Ries E, Stolba U, Binder S. Die Anwendung von r-tPA bei postoperativer Endophthalmitis nach Kataraktoperation. Spektrum Augenheilkd: in press.","DOI":"10.1007\/BF03163727"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0886-3350(13)80961-3","volume":"19","author":"GR Lesser","year":"1993","unstructured":"Lesser GR, Osher RH, Whipple D et al. Treatment of anterior chamber fibrin following cataract surgery with tissue plasminogen activator. J Cat Refract Surg 1993; 19: 301?5.","journal-title":"J Cat Refract Surg"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0161-6420(92)31815-9","volume":"99","author":"J Moon","year":"1992","unstructured":"Moon J, Chung S, Myong Y et al. Treatment of postcataract fibrinous membranes with tissue plasminogen activator. Ophthalmology 1992; 99: 1256?9.","journal-title":"Ophthalmology"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0161-6420(87)33278-6","volume":"94","author":"BJ Tripathi","year":"1987","unstructured":"Tripathi BJ, Geanon JD, Tripathi RC. Distribution of tissue plasminogen activator in human and monkey eyes. An immunohistochemical study. Ophthalmology 1987; 94: 1434?8.","journal-title":"Ophthalmology"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0002-9394(88)90707-6","volume":"106","author":"RC Tripathi","year":"1988","unstructured":"Tripathi RC, Park JK, Tripathi BJ, Millard CB. Tissue plasminogen activator in human aqueous and its possible therapeutic significance. Am J Ophthalmol 1988; 106: 719?22.","journal-title":"Am J Ophthalmol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0886-3350(13)81039-5","volume":"17","author":"F Yoshitomi","year":"1991","unstructured":"Yoshitomi F, Utsumi E, Hayashi M et al. Postoperative fluctuations of tissue plasminogen activator (t-PA) in aqueous humor of pseudophakes. J Cat Refract Surg 1991; 17: 543?6.","journal-title":"J Cat Refract Surg"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0886-3350(13)80902-9","volume":"18","author":"R Menapace","year":"1992","unstructured":"Menapace R, Amon M, Radax U. Evaluation of 200 consecutive IOGEL 1103 capsular bag lenses implanted through a small incision. J Cataract Refract Surg 1992; 18: 252?64.","journal-title":"J Cataract Refract Surg"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF00918002","volume":"16","author":"A Wedrich","year":"1992","unstructured":"Wedrich A, Menapace R, Radax U et al. Combined smallincision cataract surgery and trabeculectorny?technique and results. Intern Ophthalmol 1992; 16: 409?14.","journal-title":"Intern Ophthalmol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1755-3768.1992.tb02096.x","volume":"70","author":"C Zetterstr\ufffdm","year":"1992","unstructured":"Zetterstr\ufffdm C, Olivestedt G, Lundvall A. Exfoliation syndrome and extracapsular cataract extraction with implantation of posterior chamber lens. Acta Ophthalmol 1992; 70: 85?90.","journal-title":"Acta Ophthalmol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/archopht.1991.01080050020010","volume":"109","author":"JC Folk","year":"1991","unstructured":"Folk JC, Hershey JM, Rivers MB. Lack of effectiveness of tissue plasminogen activator 20 or more days after vitrectomy. Arch Ophthalmol 1991; 109: 614.","journal-title":"Arch Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00917830.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00917830\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00917830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T15:38:45Z","timestamp":1556552325000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00917830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995]]}},"alternative-id":["BF00917830"],"URL":"https:\/\/doi.org\/10.1007\/bf00917830","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995]]}}}